CYRX Form 4: Stefanovich Exercises Options and Executes Sell-to-Cover

Rhea-AI Filing Summary

Robert Stefanovich, Chief Financial Officer of Cryoport, Inc. (CYRX), reported option exercises and a sale on 08/19/2025. He exercised 26,164 stock options with an exercise price of $3.07, producing 26,164 shares. To cover the exercise cost, he sold 9,300 shares in multiple transactions at a weighted-average price of $8.6686 (individual sale prices ranged from $8.60 to $8.75). After these transactions he beneficially owned 207,213 shares. The option grant vests 1/48 each month beginning August 19, 2015.

Insights

Financial Analyst

TL;DR: Routine insider option exercise and partial sell-to-cover; changes holdings but appears non-material to company fundamentals.

The filing documents an exercise of 26,164 options at $3.07 and a contemporaneous sale of 9,300 shares at a weighted-average $8.6686 to cover the exercise cost. This is a common executive compensation monetization action rather than a corporate event. The post-transaction beneficial ownership is 207,213 shares. No new debt, financings, or material corporate actions are disclosed.

Corporate Governance Expert

TL;DR: Transaction follows standard vesting and sell-to-cover practices; disclosure appears complete with price range footnote.

The Form 4 shows monthly vesting (1/48) from August 2015 and includes a footnote clarifying weighted-average sale pricing and willingness to provide detailed breakdowns if requested. The filing is signed and uses the appropriate transaction codes, indicating adherence to Section 16 reporting requirements. There are no indications of unusual timing or undisclosed related-party arrangements in the form text.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STEFANOVICH ROBERT

(Last) (First) (Middle)

C/O CRYOPORT INC.

112 WESTWOOD PLACE, SUITE 350

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		M		26,164	A	$3.07	216,513	D
Common Stock	08/19/2025		S(1)		9,300	D	$8.6686(2)	207,213	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock	$3.07	08/19/2025		M			26,164	(3)	08/20/2025	Common Stock	26,164	$0	0	D

Explanation of Responses:

1. The proceeds of the sale of Common Stock were used to pay the exercise price due upon the exercise of the Stock Option reported in this Form 4.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $8.75, inclusive.

3. 1/48 of the options vested on the 20th of each month for forty-eight months beginning on August 19, 2015.

Remarks:

With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.

	/s/ Robert Stefanovich	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Cryoport CFO Robert Stefanovich report on Form 4 (CYRX)?

He reported exercising 26,164 options at an exercise price of $3.07 and selling 9,300 shares on 08/19/2025.

How many Cryoport shares did Stefanovich beneficially own after the reported transactions?

He beneficially owned 207,213 shares following the transactions reported in this Form 4.

At what price were the sold Cryoport shares transacted?

The shares were sold at a weighted-average price of $8.6686, with individual trade prices ranging from $8.60 to $8.75.

Why were shares sold in connection with the option exercise?

The filing states the proceeds from the sale were used to pay the exercise price due upon exercising the stock option.

What is the vesting schedule for the exercised options?

The options vested at a rate of 1/48 of the grant on the 20th of each month for 48 months beginning on August 19, 2015.